News

Gilead has lifted the curtain on new Phase 2/3 efficacy data for Biktarvy, revealing that the drug demonstrated high efficacy in maintaining...

A small biotech based in Clackmannanshire, Scotland expects to turnover an additional £20 million from sales of its HIV diagnostics kit after the...

Allergan has released new, but unfortunately disappointing Phase 3 data for its own therapy rapastinel, confirming that it failed to outperform...

Public satisfaction with the NHS has fallen to lowest levels since 2007, according to analysis of the 2018 British Social Attitudes (BSA)...

The humanitarian organisation Médecins Sans Frontières (MSF) has called on The Coalition for Epidemic Preparedness Innovations (CEPI) to revise...

Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with the...

A measles vaccination campaign saved tens of thousands of children’s lives in India between 2010 and 2013, according to a report published in the...

The field of depression therapy has seen its biggest leap forward in over three decades, the FDA approval of Janssen’s CIII nasal spray Spravato (...

Radiation immediately following surgery in children with the third most common form of paediatric brain tumour, ependymoma, can triple survival,...

Women scientists receive $41,000 less in federal funding than men, according to a study of nearly 54,000 grants to first time principal...